Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Novo Nordisk CEO says Wegovy oral tablets account for about 80% of new patient initiations

Novo Nordisk CEO says Wegovy oral tablets account for about 80% of new patient initiations

智通财经智通财经2026/11/04 07:30
Show original
Novo Nordisk (NVO.US) CEO: Wegovy oral tablets still account for approximately 80% of the initial medication share among new oral patients.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!